insights_auto
Pse është rritur RHHBF 4,01%?
Zhytu më thellëchevron_right
RHHBF:OTCMKTS
Roche Holding AG
460,00Â US$
arrow_upward
+4,01%(+17,73) 1D
14 tet, 4:00:00 m.d., GMT-4 · USD
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për RHHBF...
Hap
460,00Â US$
I lartë
460,00Â US$
I ulët
460,00Â US$
Kapitalizimi i tregut
362,68Â mld
VĂ«llimi mesatar
61,00
VĂ«llimi
70,00
Raporti çmim/fitim
199,84
Maksimumi 52-javor
514,08Â US$
Minimumi 52-javor
301,27Â US$
Fitimet për aksion
2,30Â US$
Beta
0,45
Aksionet në qarkullim
106,69Â mln
Numri i punonjësve
113 mijë
Hap
460,00Â US$
I lartë
460,00Â US$
I ulët
460,00Â US$
Kapitalizimi i tregut
362,68Â mld
VĂ«llimi mesatar
61,00
VĂ«llimi
70,00
Raporti çmim/fitim
199,84
Maksimumi 52-javor
514,08Â US$
Minimumi 52-javor
301,27Â US$
Fitimet për aksion
2,30Â US$
Beta
0,45
Aksionet në qarkullim
106,69Â mln
Numri i punonjësve
113 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
8 minuta më parë
Roche presents vamikibart data. Roche Holding stock is valued at CHF 326.6 billion
TipRanks
·
1 ditë më parë
Nurix Therapeutics’ High-Stakes Reliance on Roche: Cost Burdens, Control Risks and Uncertain Returns for Lead Drug Bexobrutideg
ad-hoc-news.de
·
1 ditë më parë
Hapvida signs Roche deal: target for Hapvida stock falls 10.77 percent
Reuters
·
1 ditë më parë
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Profili
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Rreth Roche Holding AG
Drejtori ekzekutivThomas Schinecker
Punonjësit113 mijë
Themeluar më1 tet 1896
SeliaBasel, Basel City, Zvicër
Sektori-
Uebsajtiroche.com